188 related articles for article (PubMed ID: 33640175)
1. Necrotizing periodontal diseases in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: A review.
Balaji TM; Varadarajan S; Sujatha G; Muruganandhan J; Shanmugapriya R; Raj AT; Patil S; Fageeh HI; Fageeh HN; Malik NH; Awan KH
Dis Mon; 2021 Sep; 67(9):101168. PubMed ID: 33640175
[TBL] [Abstract][Full Text] [Related]
2. Reviewing the oral pigmented lesions of human immunodeficiency virus with emphasis on the effect of highly active antiretroviral therapy.
Varadarajan S; Balaji TM; Kumar S N; Indu Bharkavi SK; Thangavel G; Raj AT; Patil S; Al-Iryani GM; Ali FM; Awan KH
Dis Mon; 2021 Sep; 67(9):101167. PubMed ID: 33640179
[TBL] [Abstract][Full Text] [Related]
3. Oral candidiasis in human immunodeficiency virus-infected patients under highly active antiretroviral therapy.
Shekatkar M; Kheur S; Gupta AA; Arora A; Raj AT; Patil S; Khan SS; Desai A; Carroll WB; Awan KH
Dis Mon; 2021 Sep; 67(9):101169. PubMed ID: 33640178
[TBL] [Abstract][Full Text] [Related]
4. Effect of antiretroviral therapy on viral load, CD4 cell count, and progression to acquired immunodeficiency syndrome in a community human immunodeficiency virus-infected cohort. Swiss HIV Cohort Study.
Erb P; Battegay M; Zimmerli W; Rickenbach M; Egger M
Arch Intern Med; 2000 Apr; 160(8):1134-40. PubMed ID: 10789606
[TBL] [Abstract][Full Text] [Related]
5. Comparing the sub-gingival levels of Cytomegalovirus, Epstein-Barr virus, Porphyromonas gingivalis in human immunodeficiency virus-1 seropositive patients with and without antiretroviral therapy.
Kheur S; Kulkarni M; Mahajan PG; Kheur M; Raj AT; Patil S; Awan KH
Dis Mon; 2021 Sep; 67(9):101166. PubMed ID: 33663798
[TBL] [Abstract][Full Text] [Related]
6. Periodontal Conditions in Human Immunodeficiency Virus-Positive Patients Under Highly Active Antiretroviral Therapy From a Metropolitan Area of Rio De Janeiro.
Diniz Barreto LP; Melo Dos Santos M; Gomes Bda S; Lamas Cda C; Silva DG; Silva-Boghossian CM; Soares LG; Vieira Falabella ME
J Periodontol; 2016 Apr; 87(4):338-45. PubMed ID: 26609695
[TBL] [Abstract][Full Text] [Related]
7. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.
Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
Ann Intern Med; 2002 Sep; 137(5 Pt 2):381-433. PubMed ID: 12617573
[TBL] [Abstract][Full Text] [Related]
8. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.
Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
MMWR Recomm Rep; 2002 May; 51(RR-7):1-55. PubMed ID: 12027060
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus infection: personal experience in changes in head and neck manifestations due to recent antiretroviral therapies.
Campanini A; Marani M; Mastroianni A; Cancellieri C; Vicini C
Acta Otorhinolaryngol Ital; 2005 Feb; 25(1):30-5. PubMed ID: 16080313
[TBL] [Abstract][Full Text] [Related]
10. Ocular syphilis in patients with human immunodeficiency virus/acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy.
Sudharshan S; Menia NK; Selvamuthu P; Tyagi M; Kumarasamy N; Biswas J
Indian J Ophthalmol; 2020 Sep; 68(9):1887-1893. PubMed ID: 32823409
[TBL] [Abstract][Full Text] [Related]
11. API consensus guidelines for use of antiretroviral therapy in adults (API-ART guidelines). Endorsed by the AIDS Society of India.
Gupta SB; Pujari SN; Joshi SR; Patel AK;
J Assoc Physicians India; 2006 Jan; 54():57-74. PubMed ID: 16649742
[TBL] [Abstract][Full Text] [Related]
12. Antiretroviral therapy for HIV-2 infected patients.
Smith NA; Shaw T; Berry N; Vella C; Okorafor L; Taylor D; Ainsworth J; Choudhury A; Daniels RS; El-Gadi S; Fakoya A; Moyle G; Oxford J; Tedder R; O'Shea S; de Ruiter A; Breuer J
J Infect; 2001 Feb; 42(2):126-33. PubMed ID: 11531319
[TBL] [Abstract][Full Text] [Related]
13. Glycaemic profile changes by highly active antiretroviral therapy in human immunodeficiency virus-infected patients.
Duro M; Rebelo I; Barreira S; Sarmento-Castro R; Medeiros R; Almeida C
Int J STD AIDS; 2015 Oct; 26(11):796-802. PubMed ID: 25281540
[TBL] [Abstract][Full Text] [Related]
14. Immunologic dynamics in hemophiliac patients infected with hepatitis C virus and human immunodeficiency virus: influence of antiretroviral therapy.
Yokozaki S; Takamatsu J; Nakano I; Katano Y; Toyoda H; Hayashi K; Hayakawa T; Fukuda Y
Blood; 2000 Dec; 96(13):4293-9. PubMed ID: 11110704
[TBL] [Abstract][Full Text] [Related]
15. The effect of antiretroviral therapy on the prevalence of oral manifestations in HIV-infected patients: a UK study.
Tappuni AR; Fleming GJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Dec; 92(6):623-8. PubMed ID: 11740479
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and risk factors of poor immune recovery among adult HIV patients attending care and treatment centre in northwestern Tanzania following the use of highly active antiretroviral therapy: a retrospective study.
Gunda DW; Kilonzo SB; Kamugisha E; Rauya EZ; Mpondo BC
BMC Res Notes; 2017 Jun; 10(1):197. PubMed ID: 28595630
[TBL] [Abstract][Full Text] [Related]
17. Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome.
Cattelan AM; Calabrò ML; Gasperini P; Aversa SM; Zanchetta M; Meneghetti F; De Rossi A; Chieco-Bianchi L
J Natl Cancer Inst Monogr; 2001; (28):44-9. PubMed ID: 11158206
[TBL] [Abstract][Full Text] [Related]
18. Relationship between hepatitis C virus (HCV) and insulin resistance, endothelial perturbation, and platelet activation in HIV-HCV-coinfected patients under highly active antiretroviral treatment.
de Larrañaga GF; Wingeyer SD; Puga LM; Alonso BS; Benetucci JA
Eur J Clin Microbiol Infect Dis; 2006 Feb; 25(2):98-103. PubMed ID: 16477441
[TBL] [Abstract][Full Text] [Related]
19. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy.
Hogg RS; Yip B; Chan KJ; Wood E; Craib KJ; O'Shaughnessy MV; Montaner JS
JAMA; 2001 Nov; 286(20):2568-77. PubMed ID: 11722271
[TBL] [Abstract][Full Text] [Related]
20. Drug susceptibility to etravirine and darunavir among Human Immunodeficiency Virus Type 1-derived pseudoviruses in treatment-experienced patients with HIV/AIDS in South Korea.
Kwon OK; Kim SS; Rhee JE; Kee MK; Park M; Oh HR; Choi JY
Virol J; 2015 Apr; 12():53. PubMed ID: 25879840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
